Back to Newsroom
Back to Newsroom

This 4/20 is Different: New Roadside Cannabis Test to Be Piloted by Police Departments Across the U.S.

Thursday, 20 April 2023 06:00 AM

Oculogica

NEW YORK, NY / ACCESSWIRE / April 20, 2023 / Neuro-diagnostic company Oculogica today announced the launch of OcuPro, the fastest roadside cannabis test with immediate results, along with pilots planned with several police departments across the U.S. Officers administer the 45-second long test and receive an immediate indication of recent cannabis use and impairment. The technology is based on studies of several hundred cannabis users which are in submission for publications.

Oculogica, Thursday, April 20, 2023, Press release picture



Current tests for cannabis rely on a urine, saliva or blood sample from the subject, and provide a measure of tetrahydrocannabinol (THC), the active ingredient in cannabis. THC can remain in the body for months, long after the user is no longer impaired. OcuPro differentiates between recent use within 60-90 minutes vs. use over several hours ago. Oculogica CEO, Dr. Rosina Samadani, noted, "Cannabis presence in the body does not equal impairment. Use is not illegal in many states. Driving while impaired, however, is. OcuPro addresses a huge unmet need for a scientifically and clinically validated test for impairment due to recent cannabis use."

The device can be used in manufacturing facilities and workplaces, but law enforcement has the most immediate need. Data from the Connecticut Transportation Safety Research Center shows a 10% increase in impaired driving crashes the year after cannabis was legalized, according to Marisa Auguste, Research Assistant with the organization. Maryland Officer Jayme Derbyshire says, "With cannabis legalization becoming more commonplace throughout the nation, it is important that communities take action to ensure that traffic safety isn't overlooked. With the potential for more impaired drivers, law enforcement needs to continue to improve roadside testing practices and roadside technology in order to keep roadways safe and to best determine the extent of driver impairment."

Pilot sites include police districts in Missouri. Several jurisdictions, such as Seattle, WA, are in discussion. Columbia, MO, Officer Ryan Hutton, says, "As cannabis legalization continues, the concern with driving while high continues to grow. Law enforcement officers are looking for help with detecting when consumers are impaired. Detecting these drivers are a top priority as it will help reduce serious injuries and deaths on our roadways."

Kansas City, MO, Sgt. Blake Brownlee, says, "In a legalized cannabis environment, we are in real need of a device that detects recent usage of cannabis, and impairment assessment would be ideal." Oculogica's data scientist Dr. Darryl Mayeaux says, "An assessment of impairment requires a carefully and rigorously established definition of impairment that will not inappropriately define unimpaired people as impaired."

The OcuPro device looks like futuristic binoculars. Notably, the color is bright green, in part so the device is distinct from other equipment police officers are carrying. The device will be available beyond the pilot sites in late 2023.

Oculogica, founded by a neurosurgeon, develops and manufactures products with eye-tracking-based algorithms. OcuPro builds on technology used in Oculogica's EyeBOX, the first FDA-cleared concussion diagnostic that does not require a pre-injury baseline.

Contact Information:

Cady Roedl
Customer Success Manager
[email protected]
9205173873

SOURCE: Oculogica

.
Topic:
Product Announcements
Back to newsroom
Back to Newsroom

Contact Us Today


If you have questions or want to learn more about our products, our team’s here to help!

Share by: